ALNY

328.16

0.93% -3.08

시간 외 거래: 324.01 -4.15 -1.26%

Alnylam Pharmaceuticals Inc (ALNY)

개요 뉴스 가격 이력 옵션 체인 Financials ALNY 왜 하락? 토론 예측

전일 마감가:

$331.24

열려 있는:

$331.61

하루 거래량:

1.48M

Relative Volume:

1.04

시가총액:

$43.35B

수익:

$3.21B

순이익/손실:

$43.57M

주가수익비율:

1,364.49

EPS:

0.2405

순현금흐름:

$221.36M

1주 성능:

-2.93%

1개월 성능:

-19.25%

6개월 성능:

-23.35%

1년 성능:

+17.94%

1일 변동 폭

$326.51

$340.07

1주일 범위

$326.51

$355.49

52주 변동 폭

$205.87

$495.55

Alnylam Pharmaceuticals Inc Stock (ALNY) Company Profile

명칭

Alnylam Pharmaceuticals Inc

부문

Healthcare (1114)

산업

Biotechnology (623)

전화

(617) 551-8200

주소

675 WEST KENDALL STREET, CAMBRIDGE, MA

직원

2,230

트위터

@alnylam

다음 수익 날짜

2024-10-31

최신 SEC 제출 서류

ALNY's Discussions on Twitter

Compare ALNY vs VRTX, REGN, ARGX, ONC

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
ALNY Alnylam Pharmaceuticals Inc	328.16	43.76B	3.21B	43.57M	221.36M	0.2405
VRTX Vertex Pharmaceuticals Inc	477.92	116.41B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	785.51	81.05B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	811.45	50.76B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	353.92	38.40B	4.98B	69.60M	525.67M	0.5198

Alnylam Pharmaceuticals Inc Stock (ALNY) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-01-28	재개	Barclays	Overweight
2026-01-07	재개	Oppenheimer	Outperform
2025-08-04	업그레이드	Oppenheimer	Perform → Outperform
2025-08-04	업그레이드	Wolfe Research	Underperform → Peer Perform
2025-07-30	재개	Raymond James	Outperform
2025-07-21	개시	Truist	Buy
2025-03-31	개시	Redburn Atlantic	Buy
2025-03-24	업그레이드	JP Morgan	Neutral → Overweight
2024-11-12	다운그레이드	Wolfe Research	Peer Perform → Underperform
2024-10-16	개시	Scotiabank	Sector Outperform
2024-08-16	업그레이드	Goldman	Neutral → Buy
2024-02-16	다운그레이드	Goldman	Buy → Neutral
2024-02-15	개시	Wolfe Research	Peer Perform
2023-12-08	개시	Wells Fargo	Equal Weight
2023-10-11	다운그레이드	Oppenheimer	Outperform → Perform
2023-09-29	개시	Raymond James	Outperform
2023-05-05	업그레이드	BMO Capital Markets	Market Perform → Outperform
2023-04-26	개시	SMBC Nikko	Neutral
2023-03-21	개시	Bernstein	Outperform
2023-01-18	개시	Canaccord Genuity	Buy
2022-09-09	재개	Morgan Stanley	Equal-Weight
2022-07-13	개시	Cantor Fitzgerald	Neutral
2022-06-27	다운그레이드	Guggenheim	Buy → Neutral
2022-06-07	개시	William Blair	Outperform
2022-04-25	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2022-03-01	개시	Citigroup	Buy
2022-02-03	업그레이드	Guggenheim	Neutral → Buy
2022-01-03	업그레이드	Piper Sandler	Neutral → Overweight
2021-11-22	업그레이드	Goldman	Neutral → Buy
2021-11-22	업그레이드	RBC Capital Mkts	Sector Perform → Outperform
2021-11-01	업그레이드	Oppenheimer	Perform → Outperform
2021-10-04	업그레이드	UBS	Neutral → Buy
2021-08-04	다운그레이드	Piper Sandler	Overweight → Neutral
2021-02-22	다운그레이드	Guggenheim	Buy → Neutral
2021-02-12	다운그레이드	Citigroup	Buy → Neutral
2021-02-12	재확인	H.C. Wainwright	Buy
2021-01-25	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2020-09-30	재개	Berenberg	Hold
2020-09-08	개시	Citigroup	Buy
2020-08-11	다운그레이드	Oppenheimer	Outperform → Perform
2020-05-13	개시	RBC Capital Mkts	Sector Perform
2020-05-07	다운그레이드	JP Morgan	Overweight → Neutral
2020-04-24	재개	Evercore ISI	Outperform
2020-03-19	개시	Berenberg	Buy
2019-12-19	재확인	Chardan Capital Markets	Buy
2019-11-20	개시	Oppenheimer	Outperform
2019-11-13	개시	BofA/Merrill	Buy
2019-05-23	재개	Goldman	Neutral
2019-04-12	개시	Evercore ISI	Outperform
2019-03-06	업그레이드	Evercore ISI	In-line → Outperform
2019-03-05	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2019-01-23	개시	UBS	Neutral
2018-10-01	개시	Cantor Fitzgerald	Overweight
2018-08-13	재확인	Stifel	Buy
2018-08-07	업그레이드	Stifel	Hold → Buy
2018-05-04	재확인	Stifel	Hold
2018-03-28	개시	Evercore ISI	In-line

모두보기

Alnylam Pharmaceuticals Inc 주식(ALNY)의 최신 뉴스

Feb 06, 2026

Insider Trends: Should value investors consider Alnylam Pharmaceuticals Inc2025 AllTime Highs & Risk Controlled Stock Pick Alerts - baoquankhu1.vn

Feb 06, 2026

Do Options Traders Know Something About Alnylam Pharmaceuticals Stock We Don't? - Yahoo Finance

Feb 06, 2026

Feb 05, 2026

Alnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

Feb 05, 2026

Feb 04, 2026

Is There An Opportunity With Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) 49% Undervaluation? - Yahoo Finance

Feb 04, 2026

A Look At Alnylam Pharmaceuticals (ALNY) Valuation After New Revenue Outlook And Long Term Growth Targets - simplywall.st

Feb 04, 2026

Feb 03, 2026

Alnylam Pharmaceuticals (BIT:1ALNY) Price Target Decreased by 11.40% to 411.81 - Nasdaq

Feb 03, 2026

Feb 02, 2026

Alnylam Pharmaceuticals (ALNY): Investor Outlook with a 41% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Feb 02, 2026

Should You Buy Alnylam Pharmaceuticals Before Feb. 12? - AOL.com

Feb 02, 2026

25,451 Shares in Alnylam Pharmaceuticals, Inc. $ALNY Purchased by Mediolanum International Funds Ltd - MarketBeat

Feb 02, 2026

Jan 31, 2026

Analyst Views Diverge as Alnylam Pharmaceuticals, Inc. (ALNY) Targets $5.1B Revenue and Long-Term Growth - Insider Monkey

Jan 31, 2026

Alnylam Pharmaceuticals (ALNY) Valuation Check After Recent Share Price Weakness - Yahoo Finance

Jan 31, 2026

Alnylam Pharmaceuticals (ALNY) Receives Analyst Rating Update fr - GuruFocus

Jan 31, 2026

Jan 30, 2026

Has The Recent Pullback In Alnylam Pharmaceuticals (ALNY) Opened A Valuation Opportunity? - simplywall.st

Jan 30, 2026

Morgan Stanley Issues Pessimistic Forecast for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price - MarketBeat

Jan 30, 2026

ALNY: Morgan Stanley Adjusts Price Target Amidst Equal-Weight Ra - GuruFocus

Jan 30, 2026

H.C. Wainwright raises Alnylam Pharmaceuticals stock price target on TTR franchise potential - Investing.com Canada

Jan 30, 2026

Bank of America Issues Pessimistic Forecast for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price - MarketBeat

Jan 30, 2026

Alnylam Pharmaceuticals (NASDAQ:ALNY) Given New $510.00 Price Target at HC Wainwright - MarketBeat

Jan 30, 2026

HC Wainwright & Co. Maintains Buy Rating on ALNY, Lowers Price T - GuruFocus

Jan 30, 2026

Jan 29, 2026

What analysts say about Alnylam Pharmaceuticals Inc. stockGold Moves & Safe Swing Trade Setups - Mfd.ru

Jan 29, 2026

Alnylam Pharmaceuticals Projects 2026 Revenue Around $5.3 Billion as It Focuses on a New Five-Year Strategy - Finviz

Jan 29, 2026

What Alnylam Pharmaceuticals (ALNY)'s Analyst Re-Rating on Amvuttra and Pipeline Prospects Means For Shareholders - simplywall.st

Jan 29, 2026

Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results - Business Wire

Jan 29, 2026

Whale Trades: Should I hold or sell Alnylam Pharmaceuticals Inc nowWeekly Profit Summary & Long Hold Capital Preservation Plans - baoquankhu1.vn

Jan 29, 2026

Jan 28, 2026

Barclays Initiates Coverage on Alnylam Pharmaceuticals (ALNY) wi - GuruFocus

Jan 28, 2026

Street Watch: Does Alnylam Pharmaceuticals Inc have a sustainable dividendQuarterly Investment Review & Stock Portfolio Risk Control - baoquankhu1.vn

Jan 28, 2026

J. Safra Sarasin Holding AG Has $4.34 Million Position in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

Jan 28, 2026

Alnylam Pharmaceuticals (NASDAQ:ALNY) Earns Overweight Rating from Analysts at Barclays - MarketBeat

Jan 28, 2026

Alnylam Pharmaceuticals (NASDAQ:ALNY) Fits the 'Affordable Growth' GARP Profile - Chartmill

Jan 28, 2026

Federated Hermes Inc. Boosts Holdings in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

Jan 28, 2026

Alnylam Pharmaceuticals Q4 2025 Earnings Outlook - Intellectia AI

Jan 28, 2026

Jan 27, 2026

Wells Fargo Raises Alnylam (ALNY) Revenue Estimates for Amvuttra Despite Projected Margin Compression - Finviz

Jan 27, 2026

Aug Shorts: Is Alnylam Pharmaceuticals Inc impacted by rising rates2025 Earnings Impact & Safe Investment Capital Preservation Plans - baoquankhu1.vn

Jan 27, 2026

EFG Asset Management North America Corp. Trims Stock Holdings in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

Jan 27, 2026

What are analysts’ price targets for Alnylam Pharmaceuticals Inc.Weekly Gains Summary & Stepwise Entry and Exit Trade Signals - mfd.ru

Jan 27, 2026

Jan 26, 2026

The Five Minute Read - Lowell Sun

Jan 26, 2026

Mitsubishi UFJ Trust & Banking Corp Sells 8,273 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

Jan 26, 2026

Wealth Enhancement Advisory Services LLC Boosts Holdings in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

Jan 26, 2026

Jan 25, 2026

A Look At Alnylam Pharmaceuticals (ALNY) Valuation As 2026 Revenue Guidance Signals Strong Growth Potential - simplywall.st

Jan 25, 2026

Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Popularity With Investors Is Under Threat From Overpricing - 富途牛牛

Jan 25, 2026

Jan 24, 2026

Jennison Associates LLC Has $139.02 Million Stock Position in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

Jan 24, 2026

Baillie Gifford & Co. Cuts Stock Position in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

Jan 24, 2026

Jan 22, 2026

Should Alnylam’s Aggressive 2026 Revenue Guidance Reframe the Risk‑Reward for Alnylam Pharmaceuticals (ALNY) Investors? - simplywall.st

Jan 22, 2026

31,152 Shares in Alnylam Pharmaceuticals, Inc. $ALNY Bought by Rakuten Investment Management Inc. - MarketBeat

Jan 22, 2026

Nanomedicine Market Reached USD 169.51 Billion in 2024, to Reach - openPR.com

Jan 22, 2026

Jan 21, 2026

Alnylam Pharmaceuticals CMO sells shares worth $14.99 million - MSN

Jan 21, 2026

Amyloidosis Therapeutic Market to Worth Over US$ 6.37 Billion by 2033 | Astute Analytica - GlobeNewswire Inc.

Jan 21, 2026

Jan 20, 2026

Technical Reactions to ALNY Trends in Macro Strategies - Stock Traders Daily

Jan 20, 2026

RBC Capital Maintains Rating but Lowers Alnylam Pharmaceuticals (ALNY) Price Target | ALNY Stock News - GuruFocus

Jan 20, 2026

Alnylam Pharmaceuticals (NASDAQ:ALNY) Given New $376.00 Price Target at Wells Fargo & Company - MarketBeat

Jan 20, 2026

Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Lowered to $465.00 at Royal Bank Of Canada - MarketBeat

Jan 20, 2026